Ann Pediatr Endocrinol Metab.  2019 Sep;24(3):203-206. 10.6065/apem.2019.24.3.203.

A case of treatment-induced neuropathy in an adolescent with type 1 diabetes

• Varadharaju N
• Jeevarathnam D
• Rajan M
• Ponnurangam Nagarajan V
• James S

• KMID: 2460769
• DOI: http://doi.org/10.6065/apem.2019.24.3.203

Abstract

Treatment-induced neuropathy (TIN) in diabetes is an acute and painful yet completely reversible small fiber neuropathy precipitated by a rapid improvement in glycemic control. TIN is rare in children. A 16-year-old girl developed symmetrical painful neuropathy of the foot, autonomic neuropathy, and retinopathy 5 weeks after the diagnosis of type 1 diabetes. All causative workups were negative except for a drop-in hemoglobin A(1c) (HbA(1c)) from 17.4% to 7%, which fit with a diagnosis of TIN. Following symptomatic management, her neuropathy and retinopathy completely resolved in 2 months. Currently, she is 18 years old and doing well (HbA(1c), 7.4%) without any recurrence of TIN. TIN should be suspected in any child presenting with recent-onset type 1 diabetes and acute onset neuropathy. Our case represents an unreported scenario of the rapid progression in TIN. Awareness among clinicians about this rare but completely reversible condition is necessary to ensure proper management and adherence to glycemic control.

Keyword

Painful neuropathy; Autonomic neuropathy; Type 1 diabetes mellitus; Child; Glycemic control

MeSH Terms

Adolescent*
Child
Diabetes Mellitus, Type 1
Diagnosis
Erythromelalgia
Female
Foot
Humans
Recurrence
Tin
Tin

Reference

References

1. Tran C, Philippe J, Ochsner F, Kuntzer T, Truffert A. Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathy. Swiss Med Wkly. 2015; 145:w14131.

2. Rewers MJ, Pillay K, de Beaufort C, Craig ME, Hanas R, Acerini CL, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014; 15 Suppl 20:102–14.

3. Caravati CM. Insulin neuritis: a case report. Va Med Mon. 1933; 59:745–6.

4. Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015; 138(Pt 1):43–52.

5. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry. 1983; 46:491–9.

6. Wilson JL, Sokol DK, Smith LH, Snook RJ, Waguespack SG, Kincaid JC. Acute painful neuropathy (insulin neuritis) in a boy following rapid glycemic control for type 1 diabetes mellitus. J Child Neurol. 2003; 18:365–7.

7. Llewelyn JG, Thomas PK, Fonseca V, King RH, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol. 1986; 72:157–63.

8. Mathews C, Rayman G, Buck J, Wadham C, Perkins E. Acute treatment induced diabetic neuropathy in a 15-yearold boy. In : Proceedings of the 45th Meeting of the British Society for Paediatric Endocrinology and Diabetes; 2017 Nov 22-24; Newcastle. Bristol. British Society for Paediatric Endocrinology and Diabetes. 1979.

9. Dayal D, Jayaraman D, Sankhyan N, Singhi P. Acute painful neuropathy in a girl with type 1 diabetes: long term followup. J Clin Diagn Res. 2016; 10:SD01–2.

10. Rangel MA, Baptista C, Santos F, Real MV, Campos RA, Leite AL. Acute mononeuropathy in a child with newly diagnosed type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2015; 28:341–4.

11. Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996; 39:329–35.

12. Leow MK, Wyckoff J. Under-recognised paradox of neuropathy from rapid glycaemic control. Postgrad Med J. 2005; 81:103–7.

13. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009; 72:185–92.

14. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008; 131(Pt 7):1912–25.

15. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017; 40:136–54.